Hyperamylasemia in acute carbon monoxide poisoning

Area of Science:

• Toxicology
• Biochemistry
• Internal Medicine

Background:

• Acute carbon monoxide (CO) poisoning is a significant clinical concern.
• Hyperamylasemia, elevated amylase levels, is a potential complication.
• The origin of hyperamylasemia in CO poisoning requires clarification.

Purpose of the Study:

• To investigate the prevalence and origin of hyperamylasemia in patients with acute carbon monoxide poisoning.
• To determine if the pancreas or salivary glands are the primary source of elevated amylase.

Main Methods:

• Analysis of amylase levels in patients admitted to a Trauma Intensive Care Unit.
• Isozyme studies to differentiate between pancreatic and salivary amylase.
• Comparison of amylase levels in arterial and external jugular venous blood.
• Correlation analysis with clinical parameters like consciousness and base excess, and with beta-glucuronidase levels.

Main Results:

• 39.5% of patients with acute CO poisoning exhibited hyperamylasemia.
• Isozyme analysis showed 87.5% of hyperamylasemia was of salivary type.
• No cases of purely pancreatic hyperamylasemia were observed.
• Significant differences in amylase levels between arterial and external jugular venous blood confirmed salivary gland involvement.
• Amylase levels correlated with the level of consciousness, base excess, and beta-glucuronidase levels.

Conclusions:

• Hyperamylasemia in acute carbon monoxide poisoning is predominantly of salivary origin.
• The pancreas is unlikely to be involved.
• Increased salivary gland cell membrane permeability is suggested as the mechanism.
• Amylase levels may serve as a biomarker for CO poisoning severity.